{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T04:46:12Z","timestamp":1795236372691,"version":"4.10.3"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Posttransplant immunosuppression in kidney transplant recipients is associated with an increased risk of developing cutaneous squamous cell carcinoma (CSCC), contributing to significant morbidity and mortality. Various dermatological and immunosuppression modulation strategies have been identified that may reduce the risk of CSCC, both in primary and secondary prevention settings. Recent recommendations have provided consensus regarding dermatological approaches to prevent CSCC. Comparable transplant nephrology recommendations to guide immunosuppression modulation for CSCC prevention are currently lacking, leading to marked variation in practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>To address this knowledge gap, 46 international transplant nephrology experts participated in a 3-round Delphi survey to develop consensus recommendations for CSCC secondary prevention based on the actinic damage and skin cancer index stages of CSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>The panel of experts reached consensus to consider a change in immunosuppression after multiple low-risk invasive CSCC (stage 5a, 1\/y &gt;3 y) and encouraged collaboration with dermatology to optimize dermatologic preventative care after the first CSCC. There was also consensus to prioritize azathioprine modification where this is present in an immunosuppressive regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>This study provides the first international consensus recommendations for management of immunosuppression in kidney transplant recipients at discrete stages of CSCC. Additional prospective studies are necessary to determine the optimal management of immunosuppression in this patient population. These recommendations have been endorsed by the Board of the American Society of Transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001893","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:00:07Z","timestamp":1765911607000},"page":"e1893","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement"],"prefix":"10.1097","volume":"12","author":[{"given":"Melodi Javid","family":"Whitley","sequence":"first","affiliation":[{"name":"Department of Dermatology, Duke University School of Medicine, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2023-1861","authenticated-orcid":false,"given":"Jake X.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Chapman","sequence":"additional","affiliation":[{"name":"Consultant Emeritus, Renal Unit, Westmead Hospital, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko P.J.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Leiden Transplant Center, Division of Nephrology, Department of Medicine, Leiden University Medical Center and Leiden University, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Chandran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Glennon","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University School of Medicine, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector M.","family":"Madariaga","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tufts University School of Medicine, Burlington, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Transplantation Immunogenetics Service, Lifeblood, Australian Redcross Blood Service, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Booth","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust, Royal London Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Concepcion","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Medicine, The University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Couzi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha A.","family":"De Serres","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Laval University, Quebec, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden","family":"Doyle","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Virginia Health System, Charlottesvilla, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Forbes","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, The Royal London Hospital, Bart\u2019s Health NHS Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Gleadle","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Southern Adelaide Local Health Network, Flinders Medical Centre, Bedford Park, SA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Griffin","sequence":"additional","affiliation":[{"name":"University Hospital of Wales, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshman","family":"Gunaratnam","sequence":"additional","affiliation":[{"name":"Matthew Mailing Centre for Translational Transplant Studies, Multi-Organ Transplant Program, London Health Sciences Centre, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Virginia Commonwealth University, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Winnipeg, MB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Royal Melbourne Hospital, Parkville, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Isbel","sequence":"additional","affiliation":[{"name":"Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, QLD, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dev K.","family":"Jegatheesan","sequence":"additional","affiliation":[{"name":"Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, QLD, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Jones","sequence":"additional","affiliation":[{"name":"University College London Department of Renal Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kuypers","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Renal Transplantation, University Hospitals Leuven, University of Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Texas at Austin, Austin, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai","family":"Lim","sequence":"additional","affiliation":[{"name":"Medical School, University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Mason","sequence":"additional","affiliation":[{"name":"Oxford Transplant Centre, The Churchill Hospital, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Meneghini","sequence":"additional","affiliation":[{"name":"Nephrology and Kidney Transplantation Laboratory, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Department of Nephrology and Kidney Transplantation, University Hospital Vall d'Hebron, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itunu","family":"Owoyemi","sequence":"additional","affiliation":[{"name":"Department of Kidney Medicine, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Rao","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Virginia Health System, Charlottesvilla, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Salama","sequence":"additional","affiliation":[{"name":"University College of London Centre for Kidney and Bladder Health, Division of Medicine, Faculty of Medical Sciences, University College London, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Sharif","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospitals Birmingham, Birmingham, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thaunat","sequence":"additional","affiliation":[{"name":"Service de Transplantation, N\u00e9phrolgie et Immunologie Clinique, H\u00f4pital Edouard Herriot, Hospices Civils de Lyon, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Thuraisingham","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine and Transplantation, Barts Health NHS Trust, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Wyburn","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Yabu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anokhi","family":"Jambusaria-Pahlajani","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Dell Medical School, University of Texas at Austin, Austin, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5793-4777","authenticated-orcid":false,"given":"Matthew J.","family":"Bottomley","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom."},{"name":"Oxford Kidney and Transplant Unit, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah T.","family":"Arron","sequence":"additional","affiliation":[{"name":"Peninsula Dermatology Medical Group, Burlingame, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"R1-20251216","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/bjd.15931","article-title":"Epidemiology of keratinocyte carcinomas after organ transplantation.","volume":"177","author":"Madeleine","year":"2017","journal-title":"Br J Dermatol"},{"key":"R2-20251216","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation.","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-20251216","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jamadermatol.2018.5595","article-title":"Multiple cutaneous squamous cell carcinoma in immunosuppressed vs immunocompetent patients.","volume":"155","author":"Gonzalez","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R4-20251216","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population.","volume":"13","author":"Harwood","year":"2013","journal-title":"Am J Transplant"},{"key":"R5-20251216","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/jamadermatol.2015.1702","article-title":"Outcomes of patients with multiple cutaneous squamous cell carcinomas: a 10-year single-institution cohort study.","volume":"151","author":"Levine","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R6-20251216","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/ijms20082009","article-title":"The role of the immune system in cutaneous squamous cell carcinoma.","volume":"20","author":"Bottomley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R7-20251216","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ejca.2012.01.003","article-title":"Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.","volume":"48","author":"Hollestein","year":"2012","journal-title":"Eur J Cancer"},{"key":"R8-20251216","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cam4.404","article-title":"Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality.","volume":"4","author":"Robsahm","year":"2015","journal-title":"Cancer Med"},{"key":"R9-20251216","first-page":"820","article-title":"Squamous cell carcinoma of the skin has more than doubled over the last decade in the UK.","volume":"96","author":"Goon","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"R10-20251216","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States.","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R11-20251216","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"R12-20251216","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus.","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"key":"R13-20251216","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation.","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"R14-20251216","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2017.76.6691","article-title":"Sirolimus for secondary prevention of skin cancer in kidney transplant recipients: 5-year results.","volume":"36","author":"Dantal","year":"2018","journal-title":"J Clin Oncol"},{"key":"R15-20251216","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00042728-200502000-00008","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy.","volume":"31","author":"Otley","year":"2005","journal-title":"Dermatol Surg"},{"issue":"2 Pt 1","key":"R16-20251216","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R17-20251216","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1684\/ejd.2021.4108","article-title":"The association between immunosuppression and skin cancer in solid organ transplant recipients: a control-matched cohort study of 2,852 patients.","volume":"31","author":"Gibson","year":"2021","journal-title":"Eur J Dermatol"},{"key":"R18-20251216","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature.","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"R19-20251216","article-title":"Ongoing equipoise contributes to unchanged outcomes and significant morbidity following post-transplant cutaneous squamous cell carcinoma: a multicentre cohort study.","author":"Crisp","year":"2025","journal-title":"medRxiv"},{"key":"R20-20251216","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: a Delphi consensus statement.","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R22-20251216","doi-asserted-by":"crossref","first-page":"e1004390","DOI":"10.1371\/journal.pmed.1004390","article-title":"ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: guidance and examples to support reporting consensus methods.","volume":"21","author":"Logullo","year":"2024","journal-title":"PLoS Med"},{"key":"R23-20251216","doi-asserted-by":"crossref","first-page":"e1004326","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi.","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med"},{"key":"R24-20251216","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2011.03751.x","article-title":"Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine.","volume":"12","author":"Hofbauer","year":"2012","journal-title":"Am J Transplant"},{"key":"R25-20251216","doi-asserted-by":"crossref","first-page":"10880","DOI":"10.3389\/ti.2022.10880","article-title":"Interventions after first post-transplant cutaneous squamous cell carcinoma: a proposed decision framework.","volume":"35","author":"Bottomley","year":"2022","journal-title":"Transpl Int"},{"key":"R26-20251216","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R27-20251216","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaad.2019.09.070","article-title":"Belatacept reduces skin cancer risk in kidney transplant recipients.","volume":"82","author":"Wang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R28-20251216","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaad.2024.05.068","article-title":"De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy.","volume":"91","author":"Jew","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:00:11Z","timestamp":1765911611000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001893","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}